Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Serotonin Syndrome × alpha-methyltryptophan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Serotonin Syndrome 1 Neoplasm Metastasis 1 Breast Neoplasms 1

Interventions

telotristat ethyl 5 lanreotide 2 telotristat 1 pasireotide 1 lutetium Lu 177 dotatate 1 alpha-methyltryptophan 1 Receptor-Like Protein Tyrosine Phosphatases, Class 2 1 Random Allocation 1 Panitumumab 1 Octreotide 1 Magnetic Resonance Spectroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03453489 2025-04-10

AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm

Barbara Ann Karmanos Cancer Institute

Phase 2 Completed

4 enrolled 7 charts

Serotonin Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡